CN204520845U - The two sacculus of uterine hemostasis - Google Patents

The two sacculus of uterine hemostasis Download PDF

Info

Publication number
CN204520845U
CN204520845U CN201520174285.0U CN201520174285U CN204520845U CN 204520845 U CN204520845 U CN 204520845U CN 201520174285 U CN201520174285 U CN 201520174285U CN 204520845 U CN204520845 U CN 204520845U
Authority
CN
China
Prior art keywords
sacculus
passes
uterine
mozzle
liquid pipe
Prior art date
Application number
CN201520174285.0U
Other languages
Chinese (zh)
Inventor
唐增军
段雅
Original Assignee
河北省人民医院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 河北省人民医院 filed Critical 河北省人民医院
Priority to CN201520174285.0U priority Critical patent/CN204520845U/en
Application granted granted Critical
Publication of CN204520845U publication Critical patent/CN204520845U/en

Links

Abstract

The utility model discloses the two sacculus of a kind of uterine hemostasis, its structure comprises the first sacculus that can insert uterine cavity and for passing to the first liquid pipe of described first sacculus note, tapping body and body and fix the uterine cavity mozzle of described first sacculus, mozzle upwards passes described first sacculus and offers guiding fluid hole in the section of passing, it is characterized in that, also comprise and can be placed in intravaginal second sacculus and the second liquid pipe to described second sacculus note, tapping body; The hypomere of described mozzle passes and fixes the second sacculus, and the lower open end passing the second sacculus establishes draining hole; The upper top end opening of described first liquid pipe is also positioned at the first sacculus, and body passes described first sacculus downwards, passes described second sacculus, and is provided with by-pass valve control at lower ending opening place; The upper top end opening of described second liquid pipe is in described second sacculus, and body passes the second sacculus downwards, and at lower ending opening, place is provided with by-pass valve control.This utility model can effectively treat postpartum hemorrhage disease, especially solves the problem that placenta previa causes postpartum hemorrhage to utilize medication effect undesirable, can oppress lower uterine segment better to obtain better haemostatic effect, increase the success rate of expectant treatment.

Description

The two sacculus of uterine hemostasis
Technical field
This utility model relates to and technical field of medical instruments, particularly relates to the two sacculus of a kind of uterine hemostasis.
Background technology
Postpartum hemorrhage is first reason causing maternal death, and it is the secondary severe postpartum due to uterine inertia normally.The remedy measures of postpartum hemorrhage mainly comprises Drug therapy and Bakri Balloon tamponade.The many modes by helping body of uterus to carry out shrinking of existing medicine realize hemostasis, and Balloon tamponade is then the effective measures of hemostasis by compression.When Drug therapy failure, Balloon tamponade just more aobvious its is worth.Placenta previa often causes postpartum hemorrhage, threatens patient vitals.Because placenta previa is attached to lower uterine segment, and lower uterine segment muscle layer is thinner, and it is poor to shrink, and therefore existing medication effect is not too obvious.
Utility model content
The purpose of this utility model is just to provide the two sacculus of a kind of uterine hemostasis, effectively to treat postpartum hemorrhage disease, especially solves the problem that placenta previa causes postpartum hemorrhage to utilize medication effect undesirable.
This utility model is achieved in that
Comprise the first sacculus that can insert uterine cavity and for passing to the first liquid pipe of described first sacculus note, tapping body and body and fix the uterine cavity mozzle of described first sacculus, mozzle upwards passes described first sacculus and offers guiding fluid hole in the section of passing, and also comprises and can be placed in intravaginal second sacculus and the second liquid pipe to described second sacculus note, tapping body; The hypomere of described mozzle passes and fixes the second sacculus, and the lower open end passing the second sacculus establishes draining hole; The upper top end opening of described first liquid pipe is also positioned at the first sacculus, and body passes described first sacculus downwards, passes described second sacculus, and is provided with by-pass valve control at lower ending opening place; The upper top end opening of described second liquid pipe is in described second sacculus, and body passes the second sacculus downwards, and at lower ending opening, place is provided with by-pass valve control.
This utility model is designed with the first sacculus can inserting uterine cavity and the second sacculus can inserting vagina, during use, liquid is filled to the first sacculus, the second sacculus by the first liquid pipe, the second liquid pipe, first sacculus oppresses lower uterine segment from intrauterine, second sacculus provides from the vagina reverse compressing to uterus upwards, lower uterine segment can be oppressed thus better to obtain better haemostatic effect, increase the success rate of expectant treatment.
Under technique scheme, this utility model can realize like this:
Described mozzle top is provided with at least one guiding fluid hole.
The two sacculus of described uterine hemostasis, also comprise vaginal drainage pipe, on described vaginal drainage pipe, top is between described first sacculus and described second sacculus, and tube wall has and draws liquid mouth; Described vaginal drainage pipe lower open end establishes draining hole.
Described vaginal drainage pipe top is divided into some being in charge of, each be in charge of all to have draw liquid mouth
Describedly draw the side that liquid mouth is positioned at each point of tube wall.
Accompanying drawing explanation
Fig. 1 is this utility model structural representation.
Detailed description of the invention
As shown in Figure 1, the two sacculus of uterine hemostasis comprises and being passed successively and first sacculus affixed with cyst wall and the second sacculus by uterine cavity mozzle 1, the first sacculus is stretched out in the upper end of described uterine cavity mozzle 1, and top is provided with guiding fluid hole, the hypomere of described uterine cavity mozzle 1 stretches out the second sacculus and is provided with draining hole at lower open end.The size and shape of the first sacculus 3 adapts to the size and shape of uterus uterine cavity.Second sacculus 4 is little compared with the first sacculus 3, is suitable for inserting intravaginal.This utility model is provided with for the first liquid pipe 6 to described first sacculus note, tapping body and the second liquid pipe 5 to described second sacculus note, tapping body.The upper top end opening of the first liquid pipe 6 is also positioned at the first sacculus 3, and body passes described first sacculus 3 downwards, passes described second sacculus 4, and is provided with by-pass valve control at lower ending opening place; The upper top end opening of described second liquid pipe 5 is in described second sacculus 4, and body passes the second sacculus 4 downwards, and at lower ending opening, place is provided with by-pass valve control.In this utility model, by-pass valve control is set at the first liquid pipe 6 and the second liquid pipe 5 end, can adjusts as required and keep oppressing intensity, and then obtaining optimum therapeuticing effect.
The two sacculus of uterine hemostasis of the present utility model, uterine cavity mozzle 1 top for drain should be provided with at least one guiding fluid hole 2, generally can arrange two to three guiding fluid holes being in differing heights separately.
The two sacculus of uterine hemostasis of the present utility model, also comprise vaginal drainage pipe 9, on vaginal drainage pipe 9, top is between the first sacculus and the second sacculus.Tube wall has and draws liquid mouth 8; Described vaginal drainage pipe lower open end establishes draining hole.A kind of embodiment is preferably that vaginal drainage pipe 9 top is divided into and is somely in charge of 7, each be in charge of all to offer draw liquid mouth, to guarantee to draw liquid effect.Further, good mode to draw liquid mouth 8 and be opened in the side of each point of tube wall, so, when can ensure to use, and the not oppressed blocking of this mouth.This structural design can make hemorrhage of cervix draw in time and by Timeliness coverage, to take remedy measures at any time.
Sacculus of the present utility model and mozzle, liquid injection pipe are all made with silica gel material, single use.
When this utility model uses, patient gets calculi position, from vagina, the first half i.e. the first sacculus is inserted uterine cavity, and meanwhile, the second sacculus is positioned at vagina place.Utilize syringe by the first liquid pipe to saline injection in the first sacculus, injection rate is grasped as the case may be, general maximum injection 500ml.Closing control valve after completing injection also pulls drainage tube downwards, drives the first sacculus to lower compression lower uterine segment and cervix uteri.Then, utilize syringe by the second liquid pipe to saline injection in the second sacculus, injection rate is grasped as the case may be, general maximum injection 200ml.After completing injection, closing control valve, keeps compressing intensity.Again uterine cavity drainage tube end and cervix uteri drainage tube end are connect drainage bag respectively, to observe uterus, cervix uteri internal hemorrhage situation, evaluate haemostatic effect.Use this utility model can't affect the use of catheter, need indwelling catheter to detect the voided volume of patient.

Claims (5)

1. the two sacculus of uterine hemostasis, comprise the first sacculus that can insert uterine cavity and for passing to the first liquid pipe of described first sacculus note, tapping body and body and fix the uterine cavity mozzle of described first sacculus, mozzle upwards passes described first sacculus and offers guiding fluid hole in the section of passing, it is characterized in that, also comprise and can be placed in intravaginal second sacculus and the second liquid pipe to described second sacculus note, tapping body; The hypomere of described mozzle passes and fixes the second sacculus, and the lower open end passing the second sacculus establishes draining hole; The upper top end opening of described first liquid pipe is also positioned at the first sacculus, and body passes described first sacculus downwards, passes described second sacculus, and is provided with by-pass valve control at lower ending opening place; The upper top end opening of described second liquid pipe is in described second sacculus, and body passes the second sacculus downwards, and at lower ending opening, place is provided with by-pass valve control.
2. the two sacculus of uterine hemostasis according to claim 1, it is characterized in that, described mozzle top is provided with at least one conduction hole.
3. the two sacculus of uterine hemostasis according to claim 1, it is characterized in that, also comprise vaginal drainage pipe, on described vaginal drainage pipe, top is between described first sacculus and described second sacculus, and tube wall has and draws liquid mouth; Described vaginal drainage pipe lower open end establishes draining hole.
4. the two sacculus of uterine hemostasis according to claim 3, it is characterized in that, described vaginal drainage pipe top is divided into some being in charge of, each be in charge of all to have draw liquid mouth.
5. the two sacculus of uterine hemostasis according to claim 4, is characterized in that, described in draw the side that liquid mouth is positioned at each point of tube wall.
CN201520174285.0U 2015-03-26 2015-03-26 The two sacculus of uterine hemostasis CN204520845U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201520174285.0U CN204520845U (en) 2015-03-26 2015-03-26 The two sacculus of uterine hemostasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201520174285.0U CN204520845U (en) 2015-03-26 2015-03-26 The two sacculus of uterine hemostasis

Publications (1)

Publication Number Publication Date
CN204520845U true CN204520845U (en) 2015-08-05

Family

ID=53734907

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201520174285.0U CN204520845U (en) 2015-03-26 2015-03-26 The two sacculus of uterine hemostasis

Country Status (1)

Country Link
CN (1) CN204520845U (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105411655A (en) * 2015-12-17 2016-03-23 王婧 Hemostasis sac for gynecology department
CN106264644A (en) * 2016-09-05 2017-01-04 路军丽 A kind of Novel uterine hypomere compressing balloon-system
CN107596537A (en) * 2016-07-11 2018-01-19 富士系统株式会社 Uterus foley's tube
CN111388046A (en) * 2020-03-27 2020-07-10 杭州市第一人民医院 Accurate regulation formula uterus hemostasis sacculus device of pressure

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105411655A (en) * 2015-12-17 2016-03-23 王婧 Hemostasis sac for gynecology department
CN105411655B (en) * 2015-12-17 2018-01-19 王婧 A kind of gynaecology's hemostatic bag
CN107596537A (en) * 2016-07-11 2018-01-19 富士系统株式会社 Uterus foley's tube
CN106264644A (en) * 2016-09-05 2017-01-04 路军丽 A kind of Novel uterine hypomere compressing balloon-system
CN111388046A (en) * 2020-03-27 2020-07-10 杭州市第一人民医院 Accurate regulation formula uterus hemostasis sacculus device of pressure

Similar Documents

Publication Publication Date Title
US20190151628A1 (en) Balloon catheter
Dutta et al. Gynecology
ES2714583T3 (en) Pelvic balloon tamponade
Georgiou Intraluminal pressure readings during the establishment of a positive ‘tamponade test’in the management of postpartum haemorrhage
WO2017049823A1 (en) Prostate dilation catheter
US20170035949A1 (en) Drainage system and vacuum pump for intrauterine vacuum therapy
CN104825229A (en) Variable-stiffness endoscopic surgery instrument outer sheath
DE102010019795B4 (en) Balloon catheter system for sealing puncture sites in body cavities, hollow organs or percutaneous systems in mammals
WO2008012802A3 (en) Fibroid treatment apparatus and method
CN201410215Y (en) T-shaped intracerebral hematoma drain tube
CN204411366U (en) Anus negative pressure drainage medicine injecting device
CN204932562U (en) A kind of Novel prostate dilator
Ruiz et al. Graciloplasty for rectourethral, rectovaginal and rectovesical fistulas: technique overview, pitfalls and complications
CN203138640U (en) Recanalization assembly for fallopian tube
Weiwei et al. Vaginal reconstruction with the muscle-sparing vertical rectus abdominis myocutaneous flap
CN203303395U (en) Body cavity drainage tube kit
BRPI0721423A2 (en) Surgical technique and tools for use in urinary incontinence treatment
CN110680442B (en) A sacculus system for postpartum recovery
CN204932561U (en) Cervical dilator
Chang et al. Minimizing bladder injury in laparoscopically assisted vaginal hysterectomy among women with previous cesarean sections
CN103394154B (en) A kind of for having assisted the two sacculus venous duct in three chambeies of total hepatic vascular exclusion
CN202776442U (en) Packing device for treating uterine bleeding
CN204744283U (en) Peritoneoscope pushes away knot ware
WO2015028926A1 (en) Complete flow diversion intestinal ostomy surgery kit
CN202654270U (en) Noninvasive pipe extractor for support pipe in ureter

Legal Events

Date Code Title Description
GR01 Patent grant
C14 Grant of patent or utility model
TR01 Transfer of patent right

Effective date of registration: 20170113

Address after: B 050000 area in Hebei city of Shijiazhuang province Xinshi North Road, No. 399 New Industrial Park No. 2 Building 3 layer

Patentee after: HEBEI AINENG BIOTECHNOLOGY CO., LTD.

Address before: 050071 Hebei City, Shijiazhuang province No. 348 Heping Road, No. two

Patentee before: The people's hospital of Heibei

C41 Transfer of patent application or patent right or utility model